Gonadoblastoma in Turner Syndrome: A surprise in a streak.

  title={Gonadoblastoma in Turner Syndrome: A surprise in a streak.},
  author={Jacqueline P. Morin and Amanda F. Saltzman},


Gonadal malignancy in patients with differences of sex development.
This review aims to provide an overview of the pathogenesis of DSD conditions, potential malignancies associated with the diagnoses, the available screening for malignancy, and the most recent data on stratification for each DSD diagnosis and association withmalignancy.
Oncologic outcomes of pre-malignant and invasive germ cell tumors in patients with differences in sex development - A systematic review.
The risk of GCNIS or GCT at the time of gonadal surgery appears to increase with age, accelerating between 15 and 20y regardless of risk category, and this similar trend was found in a COG review of 9 patients with DSD and ovarian GCT.
Progress in Fertility Preservation Strategies in Turner Syndrome
The etiologies of infertility is described and the fertility preservation strategies for women with TS are reviewed, which include cryopreservation of oocytes, ovarian tissues, and embryos.
Gonadal dysgenesis is associated with worse outcomes in patients with ovarian nondysgerminomatous tumors: A report of the Children's Oncology Group AGCT 0132 study
The timing and behavior of malignant ovarian germ cell tumors in pediatric patients with dysgenetic gonads compared to those with normal gonadal development are characterized.
Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting.
An international effort that started with exploratory meetings in 2014 in both Europe and the USA, and culminated with a Consensus Meeting held in Cincinnati, Ohio, USA in July 2016, the present guidelines related to the efficacy and most optimal treatment of short stature, infertility, hypertension, and hormonal replacement therapy.
Global Disorders of Sex Development Update since 2006: Perceptions, Approach and Care
The goal of this update regarding the diagnosis and care of persons with disorders of sex development (DSDs) is to address changes in the clinical approach since the 2005 Consensus Conference, since
Clinical implications of the detection of Y-chromosome mosaicism in Turner's syndrome: report of 3 cases.
A systematic search for Y-chromosome mosaicism in Turner's syndrome patients is justified by the risk of developing gonadal tumors or androgen-producing lesions.
Tumor risk in disorders of sex development (DSD).
It is proposed that morphological and histological evaluation of gonadal tissue, in combination with OCT3/4 and TSPY double immunohistochemistry and clinical parameters, is most informative in estimating the risk for germ-cell tumor development in the individual patient, and might in future be used to develop a decision tree for optimal management of patients with DSD.